EA200700707A1 - Производные 2-ациламинотиазола - Google Patents

Производные 2-ациламинотиазола

Info

Publication number
EA200700707A1
EA200700707A1 EA200700707A EA200700707A EA200700707A1 EA 200700707 A1 EA200700707 A1 EA 200700707A1 EA 200700707 A EA200700707 A EA 200700707A EA 200700707 A EA200700707 A EA 200700707A EA 200700707 A1 EA200700707 A1 EA 200700707A1
Authority
EA
Eurasian Patent Office
Prior art keywords
acylaminothiazole
derivatives
compounds
receptor
neurological
Prior art date
Application number
EA200700707A
Other languages
English (en)
Inventor
Могенс Ларсен
Аннете Гравен Самс
Гитте Миккельсен
Бенни Банг-Андерсен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200700707A1 publication Critical patent/EA200700707A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к соединениям формулы I, переменные которой определены в формуле изобретения, для применения в качестве лекарственного средства. Соединения являются лигандами A-рецептора и применимы при лечении неврологических и психических расстройств, в которые вовлечен A-рецептор.
EA200700707A 2004-09-22 2005-09-20 Производные 2-ациламинотиазола EA200700707A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61223604P 2004-09-22 2004-09-22
DKPA200401441 2004-09-22
PCT/DK2005/000591 WO2006032273A1 (en) 2004-09-22 2005-09-20 2-acylaminothiazole derivatives

Publications (1)

Publication Number Publication Date
EA200700707A1 true EA200700707A1 (ru) 2007-08-31

Family

ID=35169521

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700707A EA200700707A1 (ru) 2004-09-22 2005-09-20 Производные 2-ациламинотиазола

Country Status (8)

Country Link
US (1) US7910613B2 (ru)
EP (1) EP1794157B1 (ru)
AU (1) AU2005287729A1 (ru)
CA (1) CA2581105A1 (ru)
EA (1) EA200700707A1 (ru)
MX (1) MX2007003381A (ru)
NO (1) NO20072060L (ru)
WO (1) WO2006032273A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1700856E (pt) 2003-12-26 2016-02-19 Kyowa Hakko Kirin Co Ltd Derivado de tiazole
US7674912B2 (en) 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
US20100280023A1 (en) * 2005-06-23 2010-11-04 Kyowa Hakko Kogyo Co., Ltd. Thiazole derivatives
DK1921077T3 (en) 2005-08-02 2017-10-23 Kyowa Hakko Kirin Co Ltd Means for treating and / or preventing sleep disorders
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
EP2322223A4 (en) * 2008-07-23 2012-08-22 Kyowa Hakko Kirin Co Ltd THERAPEUTIC AGENT AGAINST MIGRAINE
TWI548411B (zh) 2009-04-28 2016-09-11 Kyowa Hakko Kirin Co Ltd Exercise disorder treatment
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE855120C (de) 1950-10-08 1953-01-05 Schering Ag Verfahren zur Herstellung von Aminosalicylsaeureamiden
CA2020437A1 (en) 1989-07-05 1991-01-06 Yoshihide Fuse Cinnamamide derivative
JP2903339B2 (ja) 1990-10-12 1999-06-07 大日精化工業株式会社 電子写真感光体
ATE254609T1 (de) 1995-05-18 2003-12-15 Zeria Pharm Co Ltd Aminothiazolderivate, sie enthaltende arzneimittel und zwischenprodukte in der herstellung dieser verbindungen
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
US6121301A (en) 1996-10-24 2000-09-19 Zeria Pharmaceutical Co., Ltd. Substituted benzoylaminothiazole derivatives and drugs containing the same
AU4506399A (en) * 1998-06-05 1999-12-30 Novartis Ag Aryl pyridinyl thiazoles
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
ATE295831T1 (de) 1999-03-10 2005-06-15 Shionogi & Co Medizinische zubereitungen mit (2.2.1) und (3.1.1)bicycloskelett die antagonisten für sowohl pgd 2? als auch txa 2? rezeptoren sind
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
KR100710100B1 (ko) 1999-04-15 2007-04-23 브리스톨-마이어스스퀴브컴파니 환형 단백질 티로신 키나제 억제제
FR2796643B1 (fr) * 1999-07-22 2005-04-29 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
AU2001260627A1 (en) 2000-06-02 2001-12-17 Shionogi And Co., Ltd. Drug composition antagonistic to both pgd2/txa2 receptors
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
GB0100624D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VII
CN1516696A (zh) 2001-01-26 2004-07-28 盐野义制药株式会社 对血小板生成素受体具有激动作用的卤素化合物
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US6713499B2 (en) 2001-12-12 2004-03-30 Hoffman-La Roche Inc. 7-Amino-benzothiazole derivatives
WO2003057689A1 (en) 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
US20040209930A1 (en) 2002-10-02 2004-10-21 Carboni Joan M. Synergistic methods and compositions for treating cancer
ATE490775T1 (de) 2002-12-19 2010-12-15 Schering Corp Verwendung von a2a rezeptor-antagonisten zur behandlung des extrapyramidalen syndroms
DE10348022A1 (de) 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
TW200524887A (en) 2003-10-27 2005-08-01 Lundbeck & Co As H N-thiazol-2-yl-benzamide derivatives
PT1700856E (pt) 2003-12-26 2016-02-19 Kyowa Hakko Kirin Co Ltd Derivado de tiazole
MX2007002584A (es) 2004-09-02 2007-09-07 Genentech Inc Inhibidores de piridilo de senalizacion de hedgehog.
US20080312435A1 (en) 2004-11-15 2008-12-18 Taisho Pharmaceutical Co., Ltd. Imine Compound
US7674912B2 (en) 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
DK1921077T3 (en) 2005-08-02 2017-10-23 Kyowa Hakko Kirin Co Ltd Means for treating and / or preventing sleep disorders
WO2007022415A2 (en) 2005-08-18 2007-02-22 Pharmacopeia, Inc. Substituted 2-aminothiazoles for treating neurodegenerative diseases

Also Published As

Publication number Publication date
US7910613B2 (en) 2011-03-22
CA2581105A1 (en) 2006-03-30
AU2005287729A1 (en) 2006-03-30
EP1794157B1 (en) 2014-02-26
US20090137642A1 (en) 2009-05-28
WO2006032273A1 (en) 2006-03-30
MX2007003381A (es) 2007-04-27
NO20072060L (no) 2007-04-23
EP1794157A1 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
EA200700909A1 (ru) Азаиндолкарбоксамиды
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
EA200700707A1 (ru) Производные 2-ациламинотиазола
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
UA92503C2 (ru) Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств
GB0510141D0 (en) Novel compounds B3
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
ATE438632T1 (de) Aryl-4-ethinylisoxazolderivate
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
NO20082096L (no) Azaindol-2-karboksamidderivativer
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
ATE466841T1 (de) 1-phenethylpiperidinderivate und ihre verwendung als opioidrezeptor-liganden
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
GB2435190A (en) Gastrin and cholecystokinin receptor ligands
EA200701758A1 (ru) Замещённые арильные производные 1,4-пиразина
TW200606148A (en) Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
EA200800562A1 (ru) Производные имидазопиридина в качестве лигандов каннабиноидного рецептора
ATE479680T1 (de) Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
TW200800960A (en) Novel 2,3-dihydroindole compounds
TW200510331A (en) Heteroaryl-substituted imidazole derivatives